Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Bold Brandicourt Plots Mega Sanofi And Boehringer Animal, Consumer Asset Swap

This article was originally published in Scrip

Executive Summary

Sanofi and Boehringer Ingelheim are in exclusive negotiations to swap parts of their businesses. The deal would involve an exchange of Sanofi's animal health business Merial, which is worth €11.4bn, with Boehringer's consumer healthcare (CHC) business, worth €6.7bn. To make up the difference in value between the two businesses, Boehringer would make a cash payment to Sanofi of €4.7bn.

Advertisement

Related Content

Sanofi CEO Upbeat Despite Medivation M&A Miss, Sarilumab Diss
3Q Pharma Results Preview: Novartis, Merck, Lilly, Bayer, GSK, Bristol, Amgen, Sanofi
Sanofi Earnings Emphasize Need For Medivation Buy
Sanofi Goes Public With Hostile Medivation Bid

Topics

Advertisement
UsernamePublicRestriction

Register